Stallion Headquartered in Ahmedabad (India) along with three Overseas offices in Vietnam, Nigeria and Angola for its international operations.
Stallion manufactures a wide range of pharmaceuticals, across the broad spectrum of therapies which includes Antidiabetics, Cardiovascular, Urology, Antibiotics – Antibacterial, Gastrointestinal, Cough & Cold, Anxiolytics & Antidepressants, Analgesics –Anti-Inflammatories, Antivirals, Antifungals, Anthelminthic, Anti protozoal, Antimalarial, Antihistaminic, Nutritional supplements and others.
Stallion has its’ strong presence in more than 50+ countries across South East Asia, Africa, Latin/central America and CIS regions.
Stallion is crowned with WHO GMP, GLP & ISO 9001-2015 Certifications after successful completion of audit by respective authorities and with their approval (15 authorities approval)
Stallion Laboratories Unit-II is New Ultra-Modern Facility designed for oral solid dosage form in compliance to latest SRA Guidelines and already applied for approval in SRA countries.
MANUFACTURING UNIT-I AT GIDC, BAVLA, AHMEDABAD :
“Manufacturing Unit-I (WHO-GMP certified) produces General Tablets, Capsules , Oral Dry Powder and Oral Liquid Formulations.”
Manufacturing Capacity:
▪ 1.8 billion of Tablets, Capsules & Sachets
▪ 6 million of Oral Liquids
MANUFACTURING UNIT-II AT GALLOPS INDUSTRIAL PARK, CHACHRAWADI VASNA, AHMEDABAD :
“New Ultra-Modern Facility designed for oral solid dosage form in compliance with Schedule M and considering SRA (Stringent Regulatory Authority) standard.”
▪ Equipped with high end modern machineries and technologies (21 CFR Complied).
▪ OSD Capacity: 2.2 billion with scope of future expansion of additional 2 lines (Capacity 4 billion)
▪ The total area of land is 11,982 Square meters including 11211.51 Square meters built up area.
Accreditation
